3 Fantastic Stocks to Buy in a New Bull Market

06:54am, Sunday, 20'th Aug 2023
Eli Lilly has explosive growth potential. Novo Nordisk is worth its premium price tag.
Sales of Lilly's (LLY) new drug, Mounjaro are already benefiting from strong demand trends. Lilly expects regulatory decisions for some key pipeline candidates this year, which are key to growth.
Eli Lilly's sales growth last quarter was driven in large part by three drugs. Trulicity remains the company's top seller, but it might not stay that way for long.

3 Reasons to Buy Eli Lilly Stock

10:00am, Wednesday, 16'th Aug 2023
Eli Lilly's newest diabetes therapy is meeting its lofty expectations. Some of the company's other medicines are also performing well.
In the comment section of a recent MarketWatch article listing stocks with high dividend yields that were expected to be well supported by the companies' cash flow, a reader suggested that it would ha
The S&P 500 rose 0.6% on Monday, Aug. 14, 2023, while the Dow and Nasdaq gained as well, as semiconductor stocks boosted the indexes.
Eli Lilly shares hit an all-time high as the drugmaker closed two acquisitions, including one related to the hot market for weight-loss treatments.
After a couple of weeks where the broad market experienced some weakness, the healthcare sector is showing considerable resiliency. Over the last month, the Healthcare Select Sector ETF  XLV  has be
Jared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.

Eli Lilly Q2: Dividends Don't Lie

02:43pm, Monday, 14'th Aug 2023
Eli Lilly and Company reported a superb Q2, triggering a sharp price rally and pushing its valuation to a very concerning level in my view. There are certainly plenty to be optimistic about, ranging f
The 'Fast Money' traders talk Eli Lilly's stellar trading week and how to play the stock moving forward.
Here are some of the major companies whose stocks moved on the week's news.

Pharma ETFs in Focus Post Q2 Earnings

01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

Why Shares of Eli Lilly Jumped This Week

11:04am, Friday, 11'th Aug 2023
Diabetes therapy Mounjaro paced the company's revenue growth. Lilly raised full-year guidance for revenue and earnings per share.
The stock has been on a strong run for the last few years, primarily due to its pipeline potential.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE